Company intelligence

PMVP

PMV Pharmaceuticals, Inc. · NASDAQ · Healthcare

Price$1.29+6.61% · +$0.08

Market cap68.8MEquity value

P / E-0.9Trailing ratio

Volume6.8MLatest session

Market data

PMVP price chart

TradingView

Related signals

1 min delayed

Browse public PMVP signals with their source context and measured market impact. Open any signal for its permanent analysis page.

PMVPSep 10, 2025+0.41% since signal

Small-Cap PMV Pharmaceuticals Cancer Drug Shows Confirmed Responses In 8 Tumor Types

PMVP released Phase 2 interim data on rezatapopt's efficacy. Overall response rate was 33% across multiple solid tumor types. Ovarian cancer had the highest response rate at 43%. Plans to submit NDA for ovarian cancer by Q1 2027. Stock dropped 23.30% to $1.23 following the announcement.

View signal analysis

Research